[go: up one dir, main page]

AU2002229850A1 - Polypeptide inducing hiv-neutralising antibodies - Google Patents

Polypeptide inducing hiv-neutralising antibodies

Info

Publication number
AU2002229850A1
AU2002229850A1 AU2002229850A AU2002229850A AU2002229850A1 AU 2002229850 A1 AU2002229850 A1 AU 2002229850A1 AU 2002229850 A AU2002229850 A AU 2002229850A AU 2002229850 A AU2002229850 A AU 2002229850A AU 2002229850 A1 AU2002229850 A1 AU 2002229850A1
Authority
AU
Australia
Prior art keywords
neutralising antibodies
inducing hiv
polypeptide inducing
polypeptide
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002229850A
Inventor
Robert Brasseur
Benoit Charloteaux
Michel Chevalier
Raphaelle El Habib
Tino Krell
Regis Sodoyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0100141A external-priority patent/FR2819256B1/en
Application filed by Aventis Pasteur SA filed Critical Aventis Pasteur SA
Publication of AU2002229850A1 publication Critical patent/AU2002229850A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention concerns a polypeptide capable of forming a structure corresponding or analogous to the intermediate state of gp41 and its use in a vaccine for preventing and treating HIV-mediated infections.
AU2002229850A 2001-01-05 2002-01-04 Polypeptide inducing hiv-neutralising antibodies Abandoned AU2002229850A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0100141A FR2819256B1 (en) 2001-01-05 2001-01-05 POLYPEPTIDE INDUCING HIV NEUTRALIZING ANTIBODIES
FR01/00141 2001-01-05
FR0100848 2001-01-23
FR01/00848 2001-01-23
PCT/FR2002/000031 WO2002053587A2 (en) 2001-01-05 2002-01-04 Polypeptide inducing hiv-neutralising antibodies

Publications (1)

Publication Number Publication Date
AU2002229850A1 true AU2002229850A1 (en) 2002-07-16

Family

ID=26212817

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002229850A Abandoned AU2002229850A1 (en) 2001-01-05 2002-01-04 Polypeptide inducing hiv-neutralising antibodies

Country Status (10)

Country Link
EP (1) EP1368478B1 (en)
AT (1) ATE324450T1 (en)
AU (1) AU2002229850A1 (en)
CA (1) CA2431881C (en)
CY (1) CY1105629T1 (en)
DE (1) DE60210936T2 (en)
DK (1) DK1368478T3 (en)
ES (1) ES2260416T3 (en)
PT (1) PT1368478E (en)
WO (1) WO2002053587A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1445614A1 (en) 2003-02-06 2004-08-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) A method for the in vitro assessment of the progression status of an HIV virus in an invidual
ES2366185T3 (en) * 2003-04-11 2011-10-18 Institut Pasteur SYNTHETIC PEPTIDES VACCINES FOR HIV: THE EPDOPE OF CBD AS AN EFFECTIVE IMMUNOGEN TO PROVIDE WIDE NEUTRALIZING ANTIBODIES AGAINST HIV.
CA2558733C (en) * 2004-02-06 2016-04-19 Inserm (Institut National De La Sante Et De La Recherche Medicale) A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
WO2014020205A2 (en) * 2012-07-31 2014-02-06 Universidad De Granada Improved anti-hiv immunogens
CN108997482B (en) 2018-08-09 2025-09-09 东莞市朋志生物科技有限公司 Synthetic peptides for detection of HIV-1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002522448A (en) * 1998-08-03 2002-07-23 ザ ユニバーシティー オブ モンタナ Prevention and treatment of viral diseases
JP2003529319A (en) * 1999-01-08 2003-10-07 キャロル ディ． ウエイス， Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41

Also Published As

Publication number Publication date
ES2260416T3 (en) 2006-11-01
WO2002053587A2 (en) 2002-07-11
EP1368478A2 (en) 2003-12-10
ATE324450T1 (en) 2006-05-15
CY1105629T1 (en) 2010-12-22
CA2431881C (en) 2011-02-22
DE60210936T2 (en) 2006-10-19
PT1368478E (en) 2006-07-31
DK1368478T3 (en) 2006-08-28
EP1368478B1 (en) 2006-04-26
CA2431881A1 (en) 2002-07-11
WO2002053587A3 (en) 2003-09-25
DE60210936D1 (en) 2006-06-01

Similar Documents

Publication Publication Date Title
BR0014282A (en) Vaccines
DK0760848T3 (en) Lactobacillus strains of human origin, their compositions and their use
WO2001034801A3 (en) Recombinant gelatin in vaccines
MXPA02007413A (en) Novel use.
AU144678S (en) Bottle
FI955315L (en) HIV protease inhibitors useful in the treatment of AIDS
YU9404A (en) Peptide-based multimeric targeted contrast agents
YU91603A (en) Crystal forms of azithromycin
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
FI923158A7 (en) HIV protease inhibitors, which are useful in the treatment of AIDS
CA98278S (en) Bottle
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2002365228A1 (en) Antigen panels and methods of using the same
YU68602A (en) Monoclonal antibodies to the human ldl receptor, their production and use
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
AU2002229850A1 (en) Polypeptide inducing hiv-neutralising antibodies
WO2002044384A3 (en) T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
AU2002233424A1 (en) Peptides having affinity for the GP120 viral protein and use thereof
CA98279S (en) Bottle
CA96704S (en) Bottle
DK0633928T3 (en) Microorganisms, their preparation and use
AU2001294786A1 (en) Use of il-8 protein modulators in the treatment of viral infections
HUP0302241A3 (en) Use of ccr5 antagonist and dp-178 polypeptide for treating viral infections
AU2002330245A1 (en) Isolated polypeptides and compositions from the venom of p. transvaalicus and methods of use
AU2002338856A1 (en) Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase